Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07418229 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 18, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
To evaluate the safety of Sinovac RSV mRNA among participants aged ≥18 years
Trial Details
NCT Number NCT07418229
Lead Sponsor Sinovac Biotech Co., Ltd
Conditions
(from sponsor)		 RSV, mRNA Vaccine
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov